Clinical Trial: Study on the Effects of SGLT2 Inhibitors on Prothrombotic State in Coronary Artery Disease and the Regulation of TRPC3/NCX1 Pathways (China)

Posted On: 2026-09-11

China, Sept. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Effects of SGLT2 Inhibitors on Prothrombotic State in Coronary Artery Disease and the Regulation of TRPC3/NCX1 Pathways'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132221

Registration Time: 2026/09/10

Type: Observational study

Primary Sponsor: Shijiazhuang People’s Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=322467

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Study on the Effects of SGLT2 Inhibitors on Prothrombotic State in Coronary Artery Disease and the Regulation of TRPC3/NCX1 Pathways (China)